Literature DB >> 11337387

Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.

M E Martin1, K Caspersen, J S Dumler.   

Abstract

Previous studies of human granulocytic ehrlichiosis (HGE) suggest a role for host immune response in resolving infection and in causing histopathological lesions. We hypothesize that interferon (IFN)-gamma allows tissue injury that is suppressed by interleukin (IL)-10 after initiation by ehrlichia infection. Thus, parental C57BL/6, IL-10-/-, and IFN-gamma-/- strains of mice were infected and then assayed for hepatic histopathological lesions, ehrlichial burden, and cytokine responses to ehrlichial antigen in primary splenic cultures during the first 21 days after infection. Histopathological severity in C57/BL6 and IL-10-/- mice rose in parallel through day 7, but then diverged as pathology in IL-10-/- mice continued to increase and remained high throughout the course of the study. The histopathological rank of C57BL/6 of mice decreased at day 10 and returned to baseline levels at days 14 and 21. In contrast, the IFN-gamma-/- strain had baseline pathology scores throughout the course of the infection, yet had significantly higher ehrlichial burden both in the blood and tissues than C57BL/6 or IL-10-/- mice. This suggests that histopathological lesions in the HGE murine model do not result from direct ehrlichia-mediated injury but from immunopathological mechanisms initiated by ehrlichial infection. The similarities with lesions in humans suggest an immunopathological basis for HGE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337387      PMCID: PMC1891945          DOI: 10.1016/s0002-9440(10)64145-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California.

Authors:  J E Madigan; S Hietala; S Chalmers; E DeRock
Journal:  J Am Vet Med Assoc       Date:  1990-06-15       Impact factor: 1.936

2.  Serum cytokine responses during acute human granulocytic ehrlichiosis.

Authors:  J S Dumler; E R Trigiani; J S Bakken; M E Aguero-Rosenfeld; G P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Variability in the 28-kDa surface antigen protein multigene locus of isolates of the emerging disease agent Ehrlichia chaffeensis suggests that it plays a role in immune evasion.

Authors:  G R Reddy; C P Streck
Journal:  Mol Cell Biol Res Commun       Date:  1999-06

4.  Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis.

Authors:  K Yoshiie; H Y Kim; J Mott; Y Rikihisa
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections.

Authors:  H Lepidi; J E Bunnell; M E Martin; J E Madigan; S Stuen; J S Dumler
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

6.  Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis.

Authors:  H M Feng; J Wen; D H Walker
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease.

Authors:  H M Feng; V L Popov; D H Walker
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Equine ehrlichiosis in northern California: 49 cases (1968-1981).

Authors:  J E Madigan; D Gribble
Journal:  J Am Vet Med Assoc       Date:  1987-02-15       Impact factor: 1.936

9.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

10.  Rickettsia conorii infection of C3H/HeN mice. A model of endothelial-target rickettsiosis.

Authors:  D H Walker; V L Popov; J Wen; H M Feng
Journal:  Lab Invest       Date:  1994-03       Impact factor: 5.662

View more
  35 in total

1.  Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum.

Authors:  R S Davies; J E Madigan; E Hodzic; D L Borjesson; J S Dumler
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

2.  Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.

Authors:  Job E Lopez; William F Siems; Guy H Palmer; Kelly A Brayton; Travis C McGuire; Junzo Norimine; Wendy C Brown
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 4.  The role of CD8 T lymphocytes in rickettsial infections.

Authors:  David H Walker; J Stephen Dumler
Journal:  Semin Immunopathol       Date:  2015-04-01       Impact factor: 9.623

5.  Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury.

Authors:  Diana G Scorpio; Friederike D von Loewenich; Heike Göbel; Christian Bogdan; J Stephen Dumler
Journal:  Clin Vaccine Immunol       Date:  2006-07

6.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

7.  Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.

Authors:  Wendy C Brown; Travis C McGuire; Waithaka Mwangi; Kimberly A Kegerreis; Henriette Macmillan; Harris A Lewin; Guy H Palmer
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis.

Authors:  Diana G Scorpio; Mustafa Akkoyunlu; Erol Fikrig; J Stephen Dumler
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

9.  Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin.

Authors:  Kyoung-Seong Choi; Justin Garyu; Jinho Park; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Sequential analysis of Anaplasma phagocytophilum msp2 transcription in murine and equine models of human granulocytic anaplasmosis.

Authors:  Diana G Scorpio; Christian Leutenegger; Jeannine Berger; Nicole Barat; John E Madigan; J Stephen Dumler
Journal:  Clin Vaccine Immunol       Date:  2007-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.